Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT01818167
Eligibility Criteria:
Inclusion Criteria:
* For inclusion, the subject must:
1. Be at least 13 years old.
2. Be otherwise healthy.
3. Have a diagnosis of HS.
4. Patients must have Hurley stage I or Stage II HS
5. Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form.
6. Agree to follow and undergo all study-related procedures.
7. If applicable, minors must have permission of legal guardian for participation in the study.
Exclusion Criteria:
* Subjects who meet the following criteria will be excluded:
1. Patients with HS Hurley stage III will be excluded from participation in the study
2. Patients who are pregnant or breast feeding will not be able to take part in the study due to the unknown effects of the topical medications.
3. Concomitant use of systemic or other topical treatments for HS not involved in current study. For cohort I, no washout period for systemic and/or topical medications will be required. For Cohort II, there will be a 14 day minimum washout period for systemic and topical treatments for HS.
4. Any reason the investigator feels the patient should not participate in the study.
5. If a patient misses ≥ 2 consecutive study visits, the patient will be excluded from further participation in this trial.
6. History of allergy to iodine or benzoyl peroxide.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
120 Years
Study:
NCT01818167
Study Brief:
Protocol Section:
NCT01818167